← Health & Life Sciences investors
Investor profile · The Signal / Midas Touch
ARCH Venture Partners
The Company Builder Behind Repeated Billion-Dollar Health Outcomes
Visit websiteWhy it made the list
ARCH is a science-led company builder focused on creating early-stage breakthrough companies, with a long record of billion-dollar outcomes.
Proof point
ARCH co-founder Robert Nelsen has helped create or finance 150+ companies, with 50+ early-stage investments reaching valuations above $1B. In June 2026, ARCH-backed Parabilis completed a $670M IPO and Kardigan a $400M IPO.
Sources: archventure.com, archventure.com, archventure.com, archventure.com
- Industry focus
- Health; Therapeutic; Diagnostics
- Technology focus
- Agnostic
- Stage
- Company Creation; Early Stage; Growth
- Geography
- Global
- Category
- The Signal / Midas Touch
Team
CS
in LinkedInCarol Suh
Partner
CR
in LinkedInCorey Ritter
Partner
NP
in LinkedInNilay Thakar, PhD
Principal
Is this investor a fit for you?
Assess your investment case and see which investors actually match your company.
Get Investor Ready